AR037679A1 - Un procedimiento para preparar una mezcla de rotameros de 4-[4-[(1r)-[4-(trifluormetil) fenil]-2-metoxietil] - (3s) - metil - 1- piperazinil] - 4- metil-1-[4,6-dimetil-5-pirimidinil) carbonilo], una mezcla de rotameros preparado por dicho procedimiento, y sales farmaceuticas de dicho compuesto basic - Google Patents
Un procedimiento para preparar una mezcla de rotameros de 4-[4-[(1r)-[4-(trifluormetil) fenil]-2-metoxietil] - (3s) - metil - 1- piperazinil] - 4- metil-1-[4,6-dimetil-5-pirimidinil) carbonilo], una mezcla de rotameros preparado por dicho procedimiento, y sales farmaceuticas de dicho compuesto basicInfo
- Publication number
- AR037679A1 AR037679A1 ARP020104560A ARP020104560A AR037679A1 AR 037679 A1 AR037679 A1 AR 037679A1 AR P020104560 A ARP020104560 A AR P020104560A AR P020104560 A ARP020104560 A AR P020104560A AR 037679 A1 AR037679 A1 AR 037679A1
- Authority
- AR
- Argentina
- Prior art keywords
- rotamers
- mixture
- methyl
- procedure
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Un procedimiento para preparar una mezcla de rotámeros de una sal de un compuesto básico donde dicha mezcla comprende uno o más rotámeros de dicha sal en un porcentaje molar superior al de sus correspondientes rotámeros de dicha sal, donde dicho procedimiento comprende hacer reaccionar dicho compuesto básico con un ácido en mezcla con un solvente. El procedimiento es para preparar directamente una relación desigual de rotámeros de una sal de ácido a partir de 4-[4-[(1R)-[4-(trifluormetil)fenil]-2-metoxietil]-(3S)-metil-1-piperazinil]-4-metil-1-[(4,6-dimetil-5-pirimidinil)carbonilo], mediante la elección creativa de un medio solvente. El procedimiento es particularmente útil para la preparación de rotámeros específicos de sales farmacéuticas útiles en la preponderancia deseada; y sales del compuesto de fórmula (1); Una mezcla de rotámeros de una sal de un compuesto básico donde dicha mezcla comprende uno o más rotámeros de la sal en un porcentaje molar superior al de sus correspondientes rotámeros de la sal, preparándose dicha sal mediante un procedimiento que comprende hacer reaccionar dicho compuesto básico con un ácido en mezcla con un solvente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33433101P | 2001-11-29 | 2001-11-29 | |
US37391602P | 2002-04-19 | 2002-04-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR037679A1 true AR037679A1 (es) | 2004-12-01 |
Family
ID=26989151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020104560A AR037679A1 (es) | 2001-11-29 | 2002-11-27 | Un procedimiento para preparar una mezcla de rotameros de 4-[4-[(1r)-[4-(trifluormetil) fenil]-2-metoxietil] - (3s) - metil - 1- piperazinil] - 4- metil-1-[4,6-dimetil-5-pirimidinil) carbonilo], una mezcla de rotameros preparado por dicho procedimiento, y sales farmaceuticas de dicho compuesto basic |
Country Status (12)
Country | Link |
---|---|
US (2) | US6943251B2 (es) |
EP (1) | EP1451174B1 (es) |
JP (2) | JP2005511693A (es) |
CN (1) | CN1596254A (es) |
AR (1) | AR037679A1 (es) |
AT (1) | ATE478065T1 (es) |
AU (1) | AU2002346569A1 (es) |
CA (1) | CA2468525A1 (es) |
DE (1) | DE60237388D1 (es) |
HK (1) | HK1063798A1 (es) |
MX (1) | MXPA04005210A (es) |
WO (1) | WO2003048153A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6689765B2 (en) * | 1999-05-04 | 2004-02-10 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
MXPA04005210A (es) * | 2001-11-29 | 2004-08-19 | Schering Corp | Procedimiento para la preparacion de composiciones que tienen una cantidad incrementada de sales farmaceuticamente activas de rotameros. |
AU2003224777A1 (en) * | 2002-03-29 | 2003-10-20 | Schering Corporation | Synthesis of piperidine and piperazine compounds as ccr5 antagonists |
US7244765B2 (en) * | 2004-06-25 | 2007-07-17 | Cytokine Pharmasciences, Inc | Guanylhydrazone salts, compositions, processes of making and methods of using |
WO2006074269A2 (en) * | 2005-01-06 | 2006-07-13 | Schering Corporation | Preparation of pharmaceutical salts of piperazine compounds |
WO2007038496A2 (en) * | 2005-09-27 | 2007-04-05 | Chemic Laboratories, Inc. | Synthesis of fatty alcohol esters of hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers |
US7561458B2 (en) * | 2006-12-26 | 2009-07-14 | Texas Instruments Incorporated | Ferroelectric memory array for implementing a zero cancellation scheme to reduce plateline voltage in ferroelectric memory |
SG183133A1 (en) * | 2010-03-11 | 2012-09-27 | Wyeth Llc | Oral formulations and lipophilic salts of methylnaltrexone |
US20170197980A1 (en) * | 2014-06-25 | 2017-07-13 | Abbvie Inc. | N-(4-phenyl)-n'-(3-fluorophenyl)urea docusate |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391865B1 (en) * | 1999-05-04 | 2002-05-21 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
RU2299206C9 (ru) * | 1999-05-04 | 2007-11-20 | Шеринг Корпорейшн | Производные пиперазина, фармацевтические композиции, их содержащие, и применение в качестве антагонистов ccr5 |
JP3874229B2 (ja) * | 1999-07-02 | 2007-01-31 | Tdk株式会社 | 圧電セラミックスおよびこれを用いた圧電デバイス |
MXPA04005210A (es) * | 2001-11-29 | 2004-08-19 | Schering Corp | Procedimiento para la preparacion de composiciones que tienen una cantidad incrementada de sales farmaceuticamente activas de rotameros. |
-
2002
- 2002-11-26 MX MXPA04005210A patent/MXPA04005210A/es active IP Right Grant
- 2002-11-26 CA CA002468525A patent/CA2468525A1/en not_active Abandoned
- 2002-11-26 JP JP2003549343A patent/JP2005511693A/ja active Pending
- 2002-11-26 AU AU2002346569A patent/AU2002346569A1/en not_active Abandoned
- 2002-11-26 DE DE60237388T patent/DE60237388D1/de not_active Expired - Lifetime
- 2002-11-26 EP EP02784638A patent/EP1451174B1/en not_active Expired - Lifetime
- 2002-11-26 US US10/304,674 patent/US6943251B2/en not_active Expired - Fee Related
- 2002-11-26 AT AT02784638T patent/ATE478065T1/de not_active IP Right Cessation
- 2002-11-26 CN CNA028238079A patent/CN1596254A/zh active Pending
- 2002-11-26 WO PCT/US2002/038112 patent/WO2003048153A1/en active Application Filing
- 2002-11-27 AR ARP020104560A patent/AR037679A1/es unknown
-
2004
- 2004-09-03 HK HK04106661.1A patent/HK1063798A1/xx not_active IP Right Cessation
-
2005
- 2005-03-30 US US11/093,560 patent/US7534884B2/en not_active Expired - Fee Related
-
2010
- 2010-03-03 JP JP2010047148A patent/JP2010132705A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US7534884B2 (en) | 2009-05-19 |
AU2002346569A1 (en) | 2003-06-17 |
EP1451174B1 (en) | 2010-08-18 |
MXPA04005210A (es) | 2004-08-19 |
US6943251B2 (en) | 2005-09-13 |
US20030144510A1 (en) | 2003-07-31 |
WO2003048153A1 (en) | 2003-06-12 |
DE60237388D1 (de) | 2010-09-30 |
EP1451174A2 (en) | 2004-09-01 |
US20050171117A1 (en) | 2005-08-04 |
ATE478065T1 (de) | 2010-09-15 |
HK1063798A1 (en) | 2005-01-14 |
CN1596254A (zh) | 2005-03-16 |
JP2005511693A (ja) | 2005-04-28 |
CA2468525A1 (en) | 2003-06-12 |
JP2010132705A (ja) | 2010-06-17 |
AU2002346569A8 (en) | 2003-06-17 |
WO2003048153A8 (en) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04004464A (es) | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. | |
CO5720995A2 (es) | Compuesto novedoso | |
AP1635A (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease. | |
PE20050018A1 (es) | Compuesto pentaciclico heteroaromatico como inhibidor de la proteina tirosina fosfatasa 1b (ptb1b) | |
AR044706A2 (es) | Procedimientos para preparar 4-aminoquinolinas, inhibidores de cetp | |
AR037679A1 (es) | Un procedimiento para preparar una mezcla de rotameros de 4-[4-[(1r)-[4-(trifluormetil) fenil]-2-metoxietil] - (3s) - metil - 1- piperazinil] - 4- metil-1-[4,6-dimetil-5-pirimidinil) carbonilo], una mezcla de rotameros preparado por dicho procedimiento, y sales farmaceuticas de dicho compuesto basic | |
EA200501462A1 (ru) | Альфа-замещенные карбоновые кислоты в качестве модуляторов ppar | |
NO20054787L (no) | Indenderivater som farmasotiske midler | |
BR0311984A (pt) | Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação | |
EA200300927A1 (ru) | Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов | |
EA200600061A1 (ru) | Бензамиды 4-(аминометил) пиперидина как 5нт-антагонисты | |
RU2002130710A (ru) | Производное пиридин-1-оксида и способ его преобразования в фармацевтически эффективные соединения | |
RU94026094A (ru) | Применение феналкиламинов | |
AR037678A1 (es) | Un procedimiento para preparar una mezcla de rotameros o pares de rotameros de una sal de 4-[(4-bromofenil)(etoximino)metil]-1'-[(2,4-dimetil-1-oxido-3-piridinil)carbonil]-4'-metil-1,4'-bipiperidina, una mezcla de rotámeros preparada por dicho procedimiento y sales de dicho compuesto basico | |
RU94046047A (ru) | Производные аминоуксусной кислоты в виде рацемата или d- и l-энантиомеров и их фармацевтически приемлемые соли, способ получения d- и l-энантиомеров производных аминоуксусной кислоты или их фармацевтически приемлемых солей и промежуточные d- и l-энантиомеры аминоуксусной кислоты в виде цинхонидиновой соли | |
NO20040388L (no) | Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten | |
MXPA04009421A (es) | Compuestos de tiazol-2-ilimina como inhibidores de la pde-7. | |
PE20030929A1 (es) | Acidos 3-(imidazolil)-2-alcoxipropanoicos | |
FI933719A (fi) | 4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol | |
FI955238A0 (fi) | Uudet 5-(aryylioksimetyyli)oksatsoliinit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
EE200200599A (et) | Tsüklipostiiniühend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,ühendi ja preparaadi valmistamine ning selleks vajalik mikroorganism | |
DK1940772T3 (da) | Ny fremgangsmåde til fremstilling af kvaternære syre- og ammoniumsalte | |
DE50311388D1 (de) | Nicht-peptidische brs-3-agonisten | |
DE602004021854D1 (de) | Pharmazeutisches präparat für die mundhöhle | |
EA200200682A1 (ru) | Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |